FDA Moves on Peptides: What Compounding Pharmacies Need to Know There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Peptides and BPC 157 for Pain: PainExam Podcast Apple Podcasts New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA moves toward easing restrictions on certain peptides BioPharma Dive